On August 11, WUXI XDC rose 3.6% in regular trading, trading at HK$64.8/share, with turnover of approximately HK$89.7 million.

On the news front, Schroders PLC purchased approximately 109,000 shares of WUXI XDC on August 6 at an average price of HK$55.3979, increasing its stake from 4.99% to 5.01% and triggering the mandatory disclosure threshold. The transaction involved approximately HK$6.04 million. Meanwhile, the company is scheduled to hold a board meeting on August 24 to review interim results for the six months ended June 30, with market expectations for the global ADC outsourcing leader's high-growth trajectory continuing to build.

Sector linkage remained evident, with WUXI BIO up 3.51%, GENSCRIPT BIO up 7.62%, and XTALPI up 3.81%. Previously, CLSA raised its target price to HK$82.6 maintaining an Outperform rating, while Daiwa initiated coverage with a Buy rating and HK$78 target, listing it as a top CXO pick in China.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)